Metis TechBio Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-391.84	-499.2	-581.93
Depreciation & Amortization	37.46	39.74	39.51
Other Amortization	0.51	0.65	2.26
Loss (Gain) From Sale of Assets	0	0.61	0.5
Asset Writedown & Restructuring Costs	0.73	1.4	61.94
Loss (Gain) From Sale of Investments	-4.63	-6.85	-0.1
Stock-Based Compensation	183.74	93.89	107.91
Other Operating Activities	34.09	147.45	131.28
Change in Accounts Receivable	0.09	0.44	-0.71
Change in Accounts Payable	-0.08	1.33	-0.26
Change in Unearned Revenue	6.11	11.08	-4.01
Change in Other Net Operating Assets	12.23	-29.74	51.18
Operating Cash Flow	-121.59	-239.21	-192.43
Capital Expenditures	-18.65	-3.34	-49.49
Sale of Property, Plant & Equipment	0.09	0.13	0.84
Sale (Purchase) of Intangibles	-0.38	-0.29	-6.97
Investment in Securities	54.86	82.43	-349.27
Other Investing Activities	-0.82	-	-
Investing Cash Flow	35.09	78.93	-404.89
Short-Term Debt Issued	40	10	30
Long-Term Debt Issued	-	-	344.32
Total Debt Issued	40	10	374.32
Short-Term Debt Repaid	-10.83	-30.33	-5.88
Long-Term Debt Repaid	-23.53	-19.91	-92.13
Total Debt Repaid	-34.37	-50.24	-98.01
Net Debt Issued (Repaid)	5.64	-40.24	276.31
Issuance of Common Stock	365.37	183.55	1,132
Repurchase of Common Stock	-	-	-84.78
Other Financing Activities	-1.53	-	-523.66
Financing Cash Flow	369.48	143.31	799.94
Foreign Exchange Rate Adjustments	-12.36	13.15	-5.62
Net Cash Flow	270.62	-3.83	197
Free Cash Flow	-140.25	-242.55	-241.92
Free Cash Flow Margin	-133.57%	-16366.46%	-2590.73%
Free Cash Flow Per Share	-1.49	-	-
Cash Income Tax Paid	0.12	0.01	0
Levered Free Cash Flow	-13.19	-20.41	-
Unlevered Free Cash Flow	6.69	84.9	-
Change in Working Capital	18.34	-16.89	46.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.